Tom Winnifrith: The Top short sellers, bears and fraudbusters all together on April 1 - don't miss out
Published 5 days ago
ShareProphets readership increases every week - we can tell because we're a registration site and if you unsubscribe, you are kicked off the site. We don't have a dead subscription list like other, lesser, sites.
Published 7 days ago
I have been greatly distracted not least dealing with this utterly brain dead and vile Cloudtag (CTAG) shareholder who has been spamming me with the most ghastly abuse all day. I look at the Bob Diamond bid for Panmure Gordon (PMR) and what it means for the wider broking/corporate advisory sector. I then turn to Premaitha (NIPT) and the wider issue of the pointlessness of commissioned research. I touch on Management Resource Solutions (MRS) in light of the news earlier HERE but now the way it is really trying to screw shareholders with a 5p placing. There is comment on Jubilee Platinum (JLP). Then it is back to two old favourites: Advanced Oncotherapy (AVO) and Milestone (MSG). Woof Woof.
Published 73 days ago
A “Christmas Trading Statement” from Majestic Wine (WINE) notes an underlying sales increase of 12.4% for the 10 weeks ending 2nd January. Sounds promising…
Published 255 days ago
1st July 2015: “Orchard Funding Group (ORCH)… is pleased to announce its flotation today on the London Stock Exchange's AIM market… will enable the business to grow to its full potential and become a leading lender in the insurance premium finance and professions finance market”. 14th April 2016: “we are pleased with how the business has grown since flotation”. Today: “the company's trading performance for the current financial year is expected to be below market expectations”. Uh oh…
Published 375 days ago
On Saturday we showed why we think that main market listed Goldenport Holdings (GPRT) is a zero following its after-hours burial of bad news on Friday. With the shares (last seen) down 52.6% today, on a spread of 8p – 9p it is red faces all round at Panmure Gordon which rated the stock a buy with a price target of 125p as recently as November 2015 (down from its previous buy recommendation with a target of 200p - itself reduced from 450p - back in April of last year).
Published 378 days ago
Tom Winnifrith was an insider which restricted him from explaining why shares in Premaitha (NIPT) have been weak of late. Now you can see. The company's largest shareholder Rupert Lywood is a total 100% prat
Published 404 days ago
The wider market is taking a bath and Premaitha (NIPT) shares are not immune to this now at 14.5p-15p. But there are also a couple of points which are company specific and in that vein we have had a detailed chat with the company on Friday.
Published 457 days ago
Everything today is delayed by last minute Christmas shopping including the duck fior Christmas day and the stocking presents for the cats and by a visit to the Conservative Club as I explain. In the podcast I again warn David Lenigas and Afriag (AFRI) shareholders that I have a special Christmas Day treat just for them, just as I had for fraudster Rob Fielding of Quindell (QPP) and the convicted Nigerian fraudster Andrew O'Dua on December 25 2014 - HERE. Elsewhere I look at Sovereign Mines of Africa (SMA), Fitbug (FITB), Game Digital (GMD), Panmure Gordon (PMR), the pensioner muggers WH Ireland (WHI), Levrett (LVRT) and the shoddy scumbags at the Mail on Sunday, Pittards (PTD) and Audioboom (BOOM).
Published 486 days ago
Having previously concluded with shares in foundries and engineering group Chamberlin (CMH) at 82.5p that I’d await further updates on the company's performance and outlook HERE, the following updates with the shares currently drifting below 70p post results for the six months ended 30th September 2015…
Published 505 days ago
Correction: NetDimension is not formally one of the ShareProphets AIM-China Filthy Forty. Apologies are therefore due to the company. Not that it is any great excuse, AIM itself states that NetDimensions' main country of operations is China (see HERE), and the FY14 Annual Report states that its principal place of business is Hong Kong - hence the confusion. NetDimensions states in its FY14 Annual Report that has operations North America, Europe, Middle East and Africa, Asia Pacific and China and thus is by no means a pure an AIM-China play. My apologies to all. That said....
Published 542 days ago
It is back to old style bearcast today as I cannot get Audioboom to work. I am sure that it is all my fault. I crow about: winning the living wage debate last night and Volex (VLX). Then it is onto Panmure Gordon (PMR), WH Ireland (WHI) - please sue me for libel bitchez - and Daniel Stewart (DAN). Then I give a good kicking to tosser Dragons Den star Piers Linney and his POS company Outsourcery (OUT)
Published 641 days ago
Panmure Gordon is house broker to Premaitha (NIPT) so take its morning note with a pinch of salt. It is paid to say buy. However for what it is worth here is its analysis of today's news and its forecasts.
Published 647 days ago
Daniel Stewart (DAN) has today been forced to say that it knows of no reason for the increase in its share price and to warn that it's bailout £1 million funding will be at a discount to the current share price. Daniel Stewart lies. The reason the shares are heading to more luducrous levels is that Rob Terry, the fraudster and insider dealer of Quindell (QPP) and The Innovation Group (TIG) infamy is ramping the shares and here is the email that proves it.
Published 818 days ago
Scancell (SCLP) is a biotech stock I’ve been keen on for some four or five years. The statistics on getting new treatments through clinical trials and regulatory approvals are terrible, so we are certainly at the high-risk end of the spectrum, but I believe the risk/reward is favourable and I like the company, management, the way it behaves (important!) and the products currently being developed. Here is why.
Published 843 days ago
Today Pharma giant Roche has snapped up a California based form Ariosa which is big in what is termed NIPT. Panmure Gordon, house broker to Premaitha (NIPT) reckons this has a clear read across for its AIM listed client. In a note sent out today it writes:
Published 869 days ago
Premaitha Health (NIPT) has updated investors attending its AGM that it believes its lead product “remains on target to be the first regulated CE marked ‘in vitro’ diagnostic product in the rapidly growing market for non-invasive prenatal screening”.
Published 876 days ago
Panmure Gordon, house broker to Premaitha (NIPT) has initiated its coverage of the stock at 18.75p. It rates the shares as a buy with a 23p target, based on applying a 30% discount to a peer group analysis. The note from analyst Mike Mitchell is a detailed 23 page study.
Published 903 days ago
It sticks in the craw when management award themselves share options at 10p when the share price is 17p. But that is what Premaitha (NIPT) announced yesterday. However
Published 906 days ago
I identified decent value in the shares of international recruitment and outsourcing services group Harvey Nash (HVN) with them trading at 70p last year. Following results for the six months ended 31st July 2014, does this remain the case at a current more than 104p?
Published 916 days ago
AIM listed Premaitha (NIPT) was our share tip of the week two weeks ago at 10.75p – the shares are now 15.75p but are still a buy from here – we expect them to double by Christmas.
Published 929 days ago
AIM listed Vialogy (VIY) was a perennial dog. That was all meant to change following the reversal of Premaitha into the business at 11p in July. So far the now renamed Premaitha Group (NIPT) has failed to sparkle. The shares are now 10.75p. But after a summer lull we reckon that is all about to change. Big time and soon. Hence it is our share tip of the week.
Published 966 days ago
A member of the HotStockRockets team owns shares in Ducat Ventures (DUC) and will not sell until we have advised you to sell. But for the avoidance of doubt when the shares hit 0.09p to sell do not wait for our call, just bank the gain.
Published 1432 days ago
Netdimensions (NETD) is a rare beast: a tech stock on AIM that is profitable, dividend paying and has a healthy cash balance.